The branded GLP-1 era is entering its next phase of growth
DAngelo S, Mele E, Di Filippo F, Viggiano A, Meccariello R
Start your intake What the Research Shows About Semaglutide and Blood Clot Risk GLP-1 receptor agonists like semaglutide were originally studied for type 2 diabetes and cardiovascular benefit
Valko et al., 2007
Taking semaglutide when your hunger tends to be strongestwhether morning, evening, or nightmay align the medication's appetite-suppressing effects with your body's peak hunger window
Microdosing GLP-1s may help stabilize appetite, improve satiety, and support energy metabolism without causing intense side effects, allowing those navigating menopause to maintain essential lean muscle mass and improve adherence to combined lifestyle and pharmaceutical care